- Home
- SNTI vs OPAL Comparison
SNTI vs OPAL Comparison
Compare SNTI & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- OPAL
- Stock Information
- Founded
- SNTI 2016
- OPAL 1998
- Country
- SNTI United States
- OPAL United States
- Employees
- SNTI N/A
- OPAL N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- OPAL Natural Gas Distribution
- Sector
- SNTI Health Care
- OPAL Utilities
- Exchange
- SNTI Nasdaq
- OPAL Nasdaq
- Market Cap
- SNTI 85.3M
- OPAL 90.7M
- IPO Year
- SNTI N/A
- OPAL N/A
- Fundamental
- Price
- SNTI $2.26
- OPAL $2.67
- Analyst Decision
- SNTI Strong Buy
- OPAL Hold
- Analyst Count
- SNTI 2
- OPAL 3
- Target Price
- SNTI $8.50
- OPAL $3.00
- AVG Volume (30 Days)
- SNTI 385.8K
- OPAL 305.4K
- Earning Date
- SNTI 08-12-2025
- OPAL 08-06-2025
- Dividend Yield
- SNTI N/A
- OPAL N/A
- EPS Growth
- SNTI N/A
- OPAL N/A
- EPS
- SNTI N/A
- OPAL 0.02
- Revenue
- SNTI N/A
- OPAL $320,427,000.00
- Revenue This Year
- SNTI N/A
- OPAL $22.40
- Revenue Next Year
- SNTI $150.00
- OPAL $19.75
- P/E Ratio
- SNTI N/A
- OPAL $134.78
- Revenue Growth
- SNTI N/A
- OPAL 15.22
- 52 Week Low
- SNTI $1.52
- OPAL $1.26
- 52 Week High
- SNTI $16.94
- OPAL $4.45
- Technical
- Relative Strength Index (RSI)
- SNTI 37.88
- OPAL 46.04
- Support Level
- SNTI $2.05
- OPAL $2.32
- Resistance Level
- SNTI $2.35
- OPAL $2.70
- Average True Range (ATR)
- SNTI 0.30
- OPAL 0.20
- MACD
- SNTI 0.00
- OPAL -0.08
- Stochastic Oscillator
- SNTI 20.00
- OPAL 32.41
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.